SS-31 FDA approval status explained: elamipretide is not FDA-approved for human use. Learn what the Barth syndrome decision means and what the safety data show.
SS-31 (elamipretide) is not FDA-approved for human use in the United States. It remains an investigational drug that has been tested in clinical trials for rare mitochondrial diseases and a few age-related conditions, but the FDA has never granted it marketing approval for any indication. Any SS-31 sold online today is a laboratory research chemical, not a prescription medicine.
What Is SS-31 (Elamipretide)?
SS-31 is a synthetic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. It is also sold and discussed under the names elamipretide, MTP-131, Bendavia, and Forzinity.
The peptide is designed to concentrate inside mitochondria and bind to cardiolipin, a lipid on the inner mitochondrial membrane. In laboratory and animal studies, that interaction is associated with improved electron transport and reduced oxidative stress. Human data are far more limited.
- Peptide class: mitochondria-targeted tetrapeptide
- Developer: Stealth BioTherapeutics
- Routes studied: subcutaneous injection and intravenous infusion
- US regulatory status: investigational; not approved for any human use
SS-31 FDA Approval Status: Where the Process Stands
Most questions about ss 31 fda approval trace back to one New Drug Application that Stealth BioTherapeutics submitted for Barth syndrome, a rare X-linked disorder that affects boys. The FDA accepted the filing, granted Priority Review, and convened an advisory committee of outside experts to review the evidence.
That committee voted that the data did not show substantial evidence of effectiveness, and the agency did not grant approval. The company has continued collecting data since then, and the picture could change if a future application succeeds.
If you are asking is ss 31 fda approved, the accurate answer today is no — not for Barth syndrome, not for mitochondrial myopathy, and not for any other condition. A future elamipretide fda approval, if it ever happens, would apply only to the specific indication the FDA reviews and approves.
Which Conditions Has Elamipretide Been Studied For?
Stealth BioTherapeutics has run trials in several rare and age-related diseases. The table below summarizes the main programs and how they are generally described in public reporting.
| Condition | Population studied | Reported status |
|---|---|---|
| Barth syndrome | Boys with the genetic disorder | Application filed; not approved after advisory committee review |
| Primary mitochondrial myopathy | Adults with genetic mitochondrial disease | Investigational; no approval |
| Dry age-related macular degeneration | Adults with dry AMD | Investigational; earlier-phase trials |
| Heart failure | Adults with heart failure | Investigational; mixed results reported |
| Healthy volunteers | Healthy adults | Early-phase research only |
Being listed in a trial table does not imply a positive result. A study can finish and still fail to show a benefit the FDA considers clinically meaningful, which is common in rare diseases where enrollment is small.
Why the FDA Has Not Approved SS-31
FDA approval of a new drug requires substantial evidence of effectiveness from adequate and well-controlled studies, plus a favorable risk-benefit assessment for the specific population. Several features of the elamipretide program make that bar difficult to clear.
- Small trials: Barth syndrome affects only a few hundred people worldwide, so studies are tiny by conventional standards.
- Subjective endpoints: Measures such as fatigue and exercise tolerance are hard to interpret when participants know whether they received the drug.
- Limited replication: Relying on a single pivotal study leaves less room for statistical uncertainty.
- Uncertain long-term safety: Rare-disease programs often have limited data on years of continuous use.
A negative advisory committee vote is not a permanent ban on a molecule. It means the evidence presented at that time was not convincing enough for the reviewers who evaluated it.
Is It Legal to Buy SS-31 Online?
Peptides labeled "for research use only" can be sold lawfully to laboratories, and SS-31 is not a controlled substance under federal law. What is not lawful is selling an unapproved peptide as a drug or dietary supplement for human consumption, which is how many consumer-facing vendors market it.
Buyers also face practical risks. Third-party testing of research peptide suppliers has repeatedly documented mislabeled or underdosed products, though results vary by vendor. Sterility is rarely guaranteed, and shipments can be seized by customs. Anyone considering a research peptide for personal use should speak with a licensed healthcare professional instead of relying on forum posts.
SS-31 Peptide Side Effects and Safety
Reported ss-31 peptide side effects in clinical trials have generally been mild. Commonly described events include injection-site reactions, headache, nausea, and dizziness. Those reports come from monitored studies using pharmaceutical-grade product, not from online vendors.
Important safety points to keep in mind:
- The long-term safety profile in humans is unknown because total exposure in trials has been limited.
- Interactions with prescription medications have not been systematically studied.
- Safety during pregnancy, breastfeeding, and in children is not established.
- Some users search for an ss-31 and mots-c protocol that stacks two mitochondria-targeted peptides. No such combination has been evaluated in FDA-regulated human trials, and there is no established dosing or safety data for using them together.
That is not a reason to self-experiment. If you have a mitochondrial disease or another chronic condition you hope to treat, ask your physician about clinical trials and about FDA expanded access, which permits unapproved drugs in specific circumstances under medical supervision.
Frequently Asked Questions
Is SS-31 FDA-approved?
No. SS-31, also called elamipretide, has not received FDA approval for any human indication. It remains an investigational drug, so it cannot legally be sold as a prescription medicine or a dietary supplement in the United States.
Are SS-31 and elamipretide the same thing?
Yes. SS-31, elamipretide, MTP-131, Bendavia, and Forzinity all refer to the same mitochondria-targeted tetrapeptide. If you see any of those names on a label or in a study, you are looking at the same molecule.
Can a US doctor prescribe SS-31?
Not as an approved treatment. Because the FDA has not approved elamipretide, a physician cannot write a standard prescription for it. Access is generally limited to clinical trials or FDA expanded access programs for patients who qualify, and those options require medical supervision.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.